Gallbladder

IWBCA
Feb 15
12 min read

The gallbladder is a small, hollow organ beneath the liver that stores, concentrates, and releases bile into the small intestine, coordinating with meals to support fat digestion and the excretion of cholesterol, bilirubin, and other waste products.

Overview

What is the gallbladder and what does it do?

The gallbladder is a pear-shaped, muscular sac that sits under the right lobe of the liver. Its primary role is to receive bile from the liver, store it between meals, concentrate it by removing water and electrolytes, and then release it into the small intestine in response to food, particularly fat and protein. By providing a bolus of concentrated bile at the right time, the gallbladder improves the efficiency of fat emulsification, nutrient absorption, and waste elimination.

The gallbladder does not produce bile; hepatocytes in the liver do. Instead, it acts as a reservoir and “dose regulator,” adjusting the timing and concentration of bile delivery to match the digestive workload. When the gallbladder is removed or nonfunctional, bile still reaches the intestine, but it flows more continuously and less concentrated, which can alter digestion for some individuals.

Anatomy

Where is the gallbladder located and how is it structured?

Location and Relations: The gallbladder lies in a shallow depression on the undersurface of the right lobe of the liver, in the right upper quadrant of the abdomen. It is closely related to the liver above, the duodenum and colon below, and the common bile duct medially. Its position explains why gallbladder pain often localizes to the right upper abdomen and may radiate to the right shoulder or back.
Macroscopic Structure: The gallbladder is usually 7 to 10 centimeters long and has three main regions: the fundus (distal, rounded end), body (central portion), and neck (proximal, tapered segment that continues as the cystic duct). The wall consists of mucosa, a muscular layer, connective tissue, and an outer serosal covering, where it is not adherent to the liver.
Cystic Duct and Biliary Tree Connection: The neck of the gallbladder leads into the cystic duct, which contains spiral folds that can influence bile flow and may trap small stones. The cystic duct joins the common hepatic duct from the liver to form the common bile duct, which carries bile toward the duodenum. This shared pathway explains how gallbladder stones can obstruct the extrahepatic bile ducts and affect the entire biliary system.
Microscopic Features: The inner lining of the gallbladder is composed of simple columnar epithelium arranged in folds that increase surface area. Beneath this layer, a muscular wall contracts to expel bile. The mucosa and muscularis are specialized for active ion and water transport, which allows the gallbladder to concentrate bile several times the strength of hepatic bile.

Bile Production and Flow

How does bile travel between the liver, gallbladder, and intestine?

Hepatic Bile Production: Hepatocytes continuously secrete bile, which contains bile acids, phospholipids, cholesterol, bilirubin, electrolytes, and water. Bile flows from tiny canaliculi between hepatocytes into progressively larger intrahepatic bile ducts and then into the right and left hepatic ducts.
Extrahepatic Duct System: The right and left hepatic ducts unite to form the common hepatic duct, which exits the liver. From there, bile can flow directly into the common bile duct and duodenum or be diverted into the cystic duct and gallbladder for storage, depending on the state of the sphincter of Oddi and gallbladder.
Sphincter of Oddi and Duodenal Entry: The common bile duct joins, or runs near, the main pancreatic duct before entering the second part of the duodenum at the major duodenal papilla. Flow is regulated by the sphincter of Oddi, a muscular ring that maintains tonic contraction between meals, directing bile toward the gallbladder and preventing continuous leakage into the intestine.
Enterohepatic Circulation of Bile Acids: Once released into the duodenum, bile acids aid fat digestion and are then reabsorbed predominantly in the terminal ileum. They return to the liver via the portal circulation, where hepatocytes extract them and resecrete them into bile. This enterohepatic circulation recycles bile acids multiple times per day, with the gallbladder serving as a key reservoir in this loop.

Physiology and Function

How does the gallbladder modify and release bile?

Bile Storage Between Meals: Between meals, when the sphincter of Oddi is closed, bile flowing from the liver is preferentially directed into the cystic duct and gallbladder. The gallbladder can hold 30 to 60 milliliters of bile, which represents a concentrated form of a much larger volume of hepatic bile.
Bile Concentration: The gallbladder epithelium actively absorbs sodium and other electrolytes, followed by water, from the bile within its lumen. This process concentrates bile acids, cholesterol, phospholipids, and bilirubin. As a result, the bile delivered during a meal has a higher detergent capacity per unit volume, improving fat emulsification and absorption.
Coordinated Emptying With Meals: When fat and partially digested protein enter the duodenum, intestinal cells release cholecystokinin. This hormone triggers gallbladder contraction and relaxation of the sphincter of Oddi, coordinating a surge of concentrated bile into the duodenum during active digestion. Vagal (parasympathetic) input and local neural pathways augment this response.
Role in Fat Digestion and Absorption: Bile acids form micelles with dietary lipids, which allow pancreatic lipase to act efficiently and facilitate the transfer of digested fats and fat-soluble vitamins into the intestinal mucosa. Without effective gallbladder emptying, this process can be less efficient, leading to bloating, steatorrhea, or deficiencies of fat-soluble vitamins in susceptible individuals.
Role in Excretion of Waste Products: The gallbladder serves as a major excretory organ for cholesterol and bilirubin. Cholesterol is eliminated in bile either as free cholesterol or after conversion into bile acids. Bilirubin, a breakdown product of hemoglobin, is conjugated in the liver and excreted into bile. Obstruction of bile flow can therefore lead to hyperbilirubinemia and jaundice.

Regulation and Control

How is gallbladder function regulated?

Cholecystokinin-Mediated Contraction: Cholecystokinin is the principal hormonal driver of gallbladder contraction. It is released from the duodenal and jejunal mucosa when lipids and certain amino acids enter the small intestine. Cholecystokinin causes robust contraction of gallbladder smooth muscle and relaxation of the sphincter of Oddi, synchronizing bile delivery with nutrient availability.
Neural Input and Vagal Stimulation: Parasympathetic fibers, carried largely in the vagus nerve, provide excitatory input to the gallbladder. Vagal stimulation during cephalic and gastric phases of digestion can prime the gallbladder to contract when food is anticipated or arrives, even before significant fat reaches the duodenum.
Fasting Motility Patterns: During fasting, the gallbladder undergoes periodic low-level motility associated with migrating motor complexes in the intestine. These cycles help prevent prolonged stasis and excessive sludge or stone formation, although they are not as intense as postprandial contractions.
Factors That Impair Emptying: Conditions such as prolonged fasting, parenteral nutrition, pregnancy, certain hormonal therapies (including estrogen and progesterone), diabetes with autonomic neuropathy, and critical illness can impair gallbladder contraction and promote bile stasis. Stasis is an important contributor to gallstone formation and to acalculous cholecystitis in high-risk patients.

Common Gallbladder Conditions

What disorders commonly affect the gallbladder and biliary system?

Gallstones (Cholelithiasis): Gallstones are solid concretions formed from supersaturated bile components, most commonly cholesterol stones and less commonly pigment stones. Many individuals with gallstones remain asymptomatic, but stones can obstruct the cystic duct or bile ducts and trigger biliary pain, inflammation, or infection. Risk factors include female sex, increasing age, obesity, rapid weight loss, pregnancy, certain medications, and hemolytic disorders.
Biliary Colic: Biliary colic refers to episodic right upper quadrant or epigastric pain that occurs when a gallstone transiently obstructs the cystic duct during gallbladder contraction. The pain is typically steady, may radiate to the right shoulder or back, and often follows a fatty meal. It usually resolves when the obstruction relieves, and there is no associated systemic inflammation in uncomplicated attacks.
Acute Calculous Cholecystitis: Acute calculous cholecystitis develops when a gallstone obstructs the cystic duct and leads to sustained gallbladder distension, inflammation, and sometimes infection. Patients typically present with prolonged right upper quadrant pain, fever, leukocytosis, and localized tenderness. Without treatment, complications such as gallbladder necrosis, perforation, or abscess can occur.
Chronic Cholecystitis: Chronic cholecystitis results from repeated episodes of gallbladder inflammation, often due to recurrent stone obstruction. Over time, the gallbladder wall can thicken and fibrose, and the organ may become shrunken and poorly contractile. Patients may report recurrent dyspeptic symptoms, intermittent pain, and intolerance of fatty foods.
Acalculous Cholecystitis: Acalculous cholecystitis is inflammation of the gallbladder without visible stones, most commonly observed in critically ill patients, those with severe trauma or burns, prolonged fasting, total parenteral nutrition, or sepsis. Gallbladder stasis, ischemia, and infection contribute to this condition, which carries a high risk of gangrene and perforation.
Choledocholithiasis and Bile Duct Obstruction: When stones migrate from the gallbladder into the common bile duct, they can obstruct bile flow and cause choledocholithiasis. Patients may develop jaundice, cholangitis (ascending infection of the biliary tree), or pancreatitis if the pancreatic duct is also obstructed. This scenario requires urgent evaluation and, in many cases, endoscopic stone removal.
Gallstone Pancreatitis: Gallstone pancreatitis occurs when a stone transiently or persistently obstructs the distal common bile duct or ampulla of Vater, impairing pancreatic juice outflow and triggering acute pancreatitis. Patients present with upper abdominal pain, elevated pancreatic enzymes, and systemic inflammatory features, and they require supportive care and, frequently, definitive management of gallstones.
Functional Gallbladder Disorder (Biliary Dyskinesia): Some individuals experience biliary-type pain without detectable stones or structural lesions. In functional gallbladder disorder, gallbladder ejection fraction measured on scintigraphy may be reduced, suggesting abnormal motility and emptying. Diagnosis requires careful exclusion of other causes of upper abdominal pain.
Gallbladder Polyps: Gallbladder polyps are mucosal outgrowths projecting into the lumen. Most are benign cholesterol polyps, but larger lesions or those with concerning features can represent adenomas or early carcinoma. Surveillance or surgical removal is recommended for polyps above certain size thresholds or in high-risk settings.
Gallbladder Cancer: Gallbladder carcinoma is an uncommon but aggressive malignancy often discovered at an advanced stage. Risk factors include long-standing gallstones, porcelain gallbladder (calcified gallbladder), large polyps, chronic inflammation, and certain anatomic variations. Symptoms are nonspecific and may mimic benign gallbladder disease, underscoring the importance of vigilance in high-risk patients.

Symptoms and Clinical Presentation

How do gallbladder and biliary problems typically present?

Asymptomatic Gallstones: Many individuals with gallstones remain entirely asymptomatic, and stones are found incidentally on imaging performed for unrelated reasons. In such cases, no specific gallbladder-related symptoms are present, and management focuses on risk assessment rather than immediate intervention.

Typical Biliary Pain Pattern: Symptomatic gallbladder disease often produces a characteristic pattern of pain in the right upper quadrant or epigastrium, frequently occurring after meals and sometimes awakening patients from sleep. The pain is usually steady, lasts from minutes to hours, and may radiate to the right scapular region or back. Nausea, vomiting, and a sense of fullness or bloating commonly accompany attacks.

Inflammatory Symptoms and Signs: Acute cholecystitis is associated with systemic features such as fever, leukocytosis, and marked right upper quadrant tenderness, sometimes with guarding or a positive Murphy sign. Patients may appear ill, and pain is more prolonged and severe than in uncomplicated biliary colic.

Obstructive Jaundice and Cholangitis: When stones or strictures obstruct the common bile duct, patients may develop jaundice, dark urine, pale stools, and generalized pruritus. Superimposed infection of the biliary tree (acute cholangitis) can present with fever, chills, jaundice, abdominal pain, and signs of sepsis, requiring urgent evaluation and drainage.

Complicated Presentations: Complications such as gallbladder perforation, gallstone ileus, empyema, or fistula formation can produce atypical symptoms, peritonitis, bowel obstruction, or recurrent infections. Associated pancreatitis presents with more diffuse upper abdominal pain radiating to the back and elevated pancreatic enzymes.

Diagnosis and Testing

How are gallbladder and biliary diseases evaluated?

Clinical Assessment: Evaluation begins with a careful history of pain characteristics, temporal relationship to meals, associated gastrointestinal symptoms, fever, and prior episodes. Physical examination focuses on abdominal tenderness, particularly in the right upper quadrant, as well as signs of jaundice, peritonitis, or systemic infection.
Laboratory Tests: Blood tests can identify inflammatory and cholestatic patterns. Leukocytosis and elevated C-reactive protein may indicate acute inflammation. Elevations in bilirubin, alkaline phosphatase, and gamma-glutamyl transferase suggest bile duct obstruction, while marked rises in aminotransferases can accompany acute obstruction or concurrent liver disease. Lipase and amylase are checked if pancreatitis is suspected.
Abdominal Ultrasound: Transabdominal ultrasound is the first-line imaging modality for suspected gallbladder disease. It can detect gallstones, sludge, gallbladder wall thickening, pericholecystic fluid, and common bile duct dilation, as well as sonographic Murphy sign. Ultrasound is noninvasive, widely available, and highly sensitive for the detection of cholelithiasis.
Hepatobiliary Scintigraphy (HIDA Scan): Hepatobiliary scintigraphy assesses bile flow from the liver into the gallbladder and intestine. Failure of the tracer to fill the gallbladder under appropriate conditions supports the diagnosis of acute cholecystitis. Ejection fraction measurement after cholecystokinin stimulation can evaluate gallbladder contractility in suspected functional gallbladder disorder.
Cross-Sectional Imaging (CT and MRI): Computed tomography can help identify complications such as perforation, abscess, or adjacent organ involvement, and can show stones that are not well visualized on ultrasound. Magnetic resonance imaging of the liver and biliary tree provides detailed soft tissue contrast and is useful in complex presentations.
MRCP and ERCP: Magnetic resonance cholangiopancreatography provides noninvasive visualization of the biliary and pancreatic ducts and can detect stones, strictures, and anatomic variants. Endoscopic retrograde cholangiopancreatography combines endoscopy and fluoroscopy to directly cannulate the bile ducts, obtain diagnostic information, and perform therapeutic interventions, including stone extraction, sphincterotomy, and stent placement.
Endoscopic Ultrasound: Endoscopic ultrasound offers high-resolution images of the gallbladder, bile ducts, and pancreas from within the gastrointestinal tract. It is particularly helpful for detecting small stones, sludge, or subtle lesions not seen on standard transabdominal imaging.

Management and Treatment

How are gallbladder disorders treated?

Conservative Management for Asymptomatic Gallstones: Most individuals with incidentally discovered gallstones and no symptoms do not require immediate intervention. Management comprises education on potential symptoms, monitoring for changes, and addressing modifiable risk factors. Prophylactic cholecystectomy may be considered in selected high-risk scenarios, such as very large stones, porcelain gallbladder, or certain hemolytic conditions.
Acute Symptom Control and Supportive Care: For biliary colic or mild cholecystitis, initial management includes pain control, antiemetics, bowel rest, and hydration. Antibiotics are added when bacterial infection is suspected or established. Early risk assessment helps determine whether urgent surgical or endoscopic intervention is required.
Cholecystectomy (Gallbladder Removal): Laparoscopic cholecystectomy is the standard definitive treatment for symptomatic cholelithiasis, acute calculous cholecystitis, certain cases of acalculous cholecystitis, functional gallbladder disorder, and selected gallbladder polyps or neoplasms. Open cholecystectomy is reserved for complex anatomy, extensive inflammation, previous abdominal operations, or when laparoscopy is not feasible or safe.
Endoscopic and Radiologic Interventions: For choledocholithiasis, cholangitis, or gallstone pancreatitis, endoscopic retrograde cholangiopancreatography with sphincterotomy and stone extraction is often indicated. In critically ill patients who are poor surgical candidates, percutaneous cholecystostomy can provide temporary or definitive drainage of an inflamed gallbladder.
Medical Dissolution Therapy: Ursodeoxycholic acid may help dissolve selected small cholesterol stones in patients who are unsuitable candidates for surgery and who have a functioning gallbladder and a patent cystic duct. This approach requires prolonged therapy and is suitable only for a narrow subset of patients.
Oncologic Management: Gallbladder carcinoma and other biliary malignancies may require extended cholecystectomy with hepatic resection and lymphadenectomy, systemic therapy, or palliative interventions to relieve obstruction and pain. Management is typically coordinated through multidisciplinary oncologic teams.
Postoperative and Long-Term Care: After cholecystectomy, most patients recover quickly, particularly after laparoscopic procedures. Follow-up includes monitoring for wound issues, bile leaks, or retained stones. Over the long term, some individuals may notice changes in bowel habits or new dyspeptic symptoms, which are usually manageable with dietary modifications and supportive care.

Living Without A Gallbladder

What happens after the gallbladder is removed?

Changes in Bile Flow: After cholecystectomy, bile flows continuously from the liver through the bile ducts into the duodenum rather than being stored and concentrated. The digestive system adapts to this pattern, and most individuals maintain adequate fat digestion without major difficulties.
Digestive Effects and Symptom Patterns: A subset of patients experience looser stools, urgency, or mild fat intolerance, particularly after large or very fatty meals. These changes are usually mild and can often be improved by spreading fat intake throughout the day, avoiding very large meals, and adjusting specific food choices.
Long-Term Outlook: For most people, removal of a diseased gallbladder alleviates biliary pain and markedly reduces the risk of recurrent cholecystitis, choledocholithiasis, and gallstone pancreatitis. The long-term prognosis is generally excellent, provided that coexisting liver or biliary conditions are addressed and that patients receive appropriate follow-up when new symptoms arise.

Protection and Prevention

How can people lower their risk of gallbladder disease?

Body Weight and Metabolic Health: Maintaining a healthy body weight and avoiding rapid, extreme weight loss can reduce the risk of cholesterol gallstone formation. Gradual, sustainable weight reduction strategies are preferred when obesity is present, and metabolic conditions such as insulin resistance and hyperlipidemia should be managed proactively.
Dietary Patterns: Patterns that emphasize fiber-rich foods, fruits, and vegetables, and moderate intake of unsaturated fats, while limiting very high-cholesterol and refined-carbohydrate intake, may lower gallstone risk. Regular meal patterns help promote consistent gallbladder emptying and reduce bile stasis.
Physical Activity: Regular physical activity supports a healthy weight, improves insulin sensitivity, and may indirectly lower the risk of gallstone formation and biliary complications.
Medication and Hormonal Influences: Certain medications, including estrogen-containing therapies and some lipid-lowering agents, can influence bile composition and gallstone risk. For individuals with multiple risk factors, clinicians may consider these effects when selecting therapy and counsel patients accordingly.
Monitoring High-Risk Groups: Individuals with hemolytic anemias, morbid obesity, rapid weight loss after bariatric surgery, primary sclerosing cholangitis, or strong family histories of gallbladder disease or gallbladder cancer may warrant closer monitoring and earlier discussion of preventive or definitive interventions.

By understanding the structure, function, and vulnerabilities of the gallbladder, clinicians and patients can recognize symptoms early, target modifiable risk factors, and choose timely interventions that prevent complications and support long-term digestive health.

The IWBCA provides the information and materials on this site for educational and informational purposes only. The content is not a substitute for professional medical evaluation, diagnosis, or treatment. Always consult your physician or another qualified healthcare provider regarding any questions you may have about a medical condition, diagnosis, or course of treatment. Do not disregard, delay, or alter medical advice based on information obtained from this site. If you believe you are experiencing a medical emergency, call 911 or your local emergency services immediately.